116
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Experiences and Views of Medicine Information Among the General Public in Thailand

ORCID Icon, , & ORCID Icon
Pages 1073-1082 | Published online: 30 Jun 2020

References

  • Raynor DK, Savage I, Knapp P, Henley J. We are the experts: people with asthma talk about their medicine information needs. Patient Educ Couns. 2004;53(2):167–174. doi:10.1016/S0738-3991(03)00126-5
  • Al-Saffar N, Deshmukh AA, Carter P, Adib SM. Effect of information leaflets and counselling on antidepressant adherence: open randomised controlled trial in a psychiatric hospital in Kuwait. Int J Pharm Pract. 2005;13(2):123–132. doi:10.1211/0022357056181
  • Hamrosi K, Dickinson R, Knapp P, et al. It’s for your benefit: exploring patients’ opinions about the inclusion of textual and numerical benefit information in medicine leaflets. Int J Pharm Pract. 2013;21(4):216–225. doi:10.1111/j.2042-7174.2012.00253.x
  • Schmitt MR, Miller MJ, Harrison DL, et al. Communicating non-steroidal anti-inflammatory drug risks: verbal counseling, written medicine information, and patients’ risk awareness. Patient Educ Couns. 2011;83(3):391–397. doi:10.1016/j.pec.2010.10.032
  • Knapp P, Raynor DK, Berry DC. Comparison of two methods of presenting risk information to patients about the side effects of medicines. Qual Saf Heal Care. 2004;13(3):176–180. doi:10.1136/qshc.2003.009076
  • Maclennan K, Brounéus F, Parkin L. Public knowledge and desire for knowledge about drug safety issues: a survey of the general public in New Zealand. Pharmaceut Med. 2016;30:339–348.
  • Phueanpinit P, Pongwecharak J, Krska J, Jarernsiripornkul N. Knowledge and perceptions of the risks of non-steroidal anti-inflammatory drugs among orthopaedic patients in Thailand. Int J Clin Pharm. 2016;38(5):1269–1276. doi:10.1007/s11096-016-0363-9
  • Hamrosi KK, Raynor DK, Aslani P. Pharmacist and general practitioner ambivalence about providing written medicine information to patients – a qualitative study. Res Soc Adm Pharm. 2013;9(5):517–530. doi:10.1016/j.sapharm.2013.02.006
  • Jarernsiripornkul N, Phueanpinit P, Pongwecharak J, Krska J. Experiences of and attitudes towards receiving information about non-steroidal anti-inflammatory drugs: a cross-sectional survey of patients in Thailand. Expert Opin Drug Saf. 2016;338:1–10.
  • Rajesh R, Vidyasagar S, Varma DM, Guddattu V, Hameed A. Evaluating the impact of educational interventions on use of highly active antiretroviral therapy and adherence behavior in Indian human immunodeficiency virus positive patients: prospective randomized controlled study. J AIDS Clin Res. 2013;4:231.
  • Akour A, Bardaweel S, Awwad O, Al-Muhaissen S, Hussein R. Impact of a pharmacist-provided information booklet on knowledge and attitudes towards oral contraception among Jordanian women: an interventional study. Eur J Contracept Reprod Heal Care. 2017;22:459–464. doi:10.1080/13625187.2017.1412425
  • Mai A, Aslani P. Impact of Vietnamese written and verbal medicine information on Vietnamese-speaking Australians‘ knowledge and satisfaction. Br J Clin Pharmacol. 2007;64(4):527–535. doi:10.1111/j.1365-2125.2007.02968.x
  • Morrow DG, Weiner M, Young J, Steinley D. Improving medication knowledge among older adults with heart failure: a patient-centered approach to instruction design. Gerontologist. 2005;45(4):545–552. doi:10.1093/geront/45.4.545
  • Smith KG, Booth JL, Stewart D, Pfleger S, McIver L, Maclure K. Supporting shared decision-making and people’s understanding of medicines: an exploration of the acceptability and comprehensibility of patient information. Pharm Pract (Granada). 2017;15:1–7.
  • Abanmy NO, Al-quait NA, Alami AH, Al-juhani MH, Al-aqeel S. The utilization of Arabic online drug information among adults in Saudi Arabia. Saudi Pharm J. 2012;20(4):317–321. doi:10.1016/j.jsps.2012.07.001
  • Ciciriello S, Johnston RV, Osborne RH, et al. Multimedia educational interventions for consumers about prescribed and over-the-counter medications. Cochrane Database Syst Rev. 2013;30:CD008416.
  • Phueanpinit P, Pongwecharak J, Krska J, Jarernsiripornkul N. Medicine information leaflets for non-steroidal anti-inflammatory drugs in Thailand. Int J Clin Pharm. 2016;38(1):25–29. doi:10.1007/s11096-015-0220-2
  • Pongpunna S, Pratipanawatr T, Jarernsiripornkul N. Survey of outpatients’ use and needs of patient medicine information leaflets in Thailand. Int J Clin Pharm. 2018;41:141–150. doi:10.1007/s11096-018-0748-z
  • Division of Innovative Health Products and Services, Food and Drug Administration [homepage on the Internet]. Guideline for leaflet development for drug research and innovation; 2019. Available from: www.fda.moph.go.th/sites/oss/Shared%20Documents/SmPC-PIL_HPEP%20guideline_updated%20May2019.pdf. Accessed March 25, 2020.
  • Liu F, Abdul-Hussain S, Mahboob S, Rai V, Kostrzewski A. How useful are medication patient information leaflets to older adults? A content, readability and layout analysis. Int J Clin Pharm. 2014;36(4):827–834. doi:10.1007/s11096-014-9973-2
  • Al-Aqeel SA. Evaluation of medication package inserts in Saudi Arabia. Drug Healthc Patient Saf. 2012;4(1):33–38. doi:10.2147/DHPS.S29402
  • Ramdas D, Chakraborty A, Swaroop H, Faizan S, Praveen Kumar V, Srinivas BN. A study of package inserts in Southern India. J Clin Diagnostic Res. 2013;7(11):2475–2477.
  • Patsuree A, Krska J, Jarernsiripornkul N. Experiences relating to adverse drug reactions in the community: a cross-sectional survey among patients and the general public in Thailand. Expert Opin Drug Saf. 2016;338:1–9.
  • Samma K, Youngpattana W, Srinonghang S Experience of adverse reaction and behavior of taking herbal medicines and dietary supplement [Unpublished Report]. Khon Kaen: Khon Kaen University; 2017.
  • Phueanpinit P, Jarernsiripornkul N, Pongwecharak J, Krska J. Hospital pharmacists’ roles and attitudes in providing information on the safety of non-steroidal anti-inflammatory drugs in Thailand. Int J Clin Pharm. 2014;36(6):1205–1212. doi:10.1007/s11096-014-0018-7
  • Jay E, Aslani P, Raynor D. User testing of consumer medicine information in Australia. Health Educ J. 2010;70:420–427. doi:10.1177/0017896910376131
  • Hamrosi KK, Raynor DK, Aslani P. Pharmacist, general practitioner and consumer use of written medicine information in Australia: are they on the same page? Res Soc Adm Pharm. 2014;10(4):656–668. doi:10.1016/j.sapharm.2013.10.002
  • The Medicines and Healthcare Products Regulatory Agency [homepage on the Internet]. Best practice guidance on patient information leaflets; 2012. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/328405/Best_practice_guidance_on_patient_information_leaflets.pdf. Accessed February 20, 2012.
  • Raynor D, Silcock J, Knapp P, Edmondson H. How do patients use medicine information leaflets in the UK? Int J Pharm Pract. 2007;15(3):209–218. doi:10.1211/ijpp.15.3.0008
  • Afolabi MO, Akinwale VO, Akinyemi OA, Irinoye AI. Patient use and perception of medicine information leaflets. Pharmacoepidemiol Drug Saf. 2012;21:110.
  • Rahim N, Rafiq K, Iffat W, Nesar S, Shakeel S. Patients comprehension of pharmaceutical package inserts information in Karachi, Pakistan. Trop J Pharm Res. 2015;14(12):2307–2311. doi:10.4314/tjpr.v14i12.22
  • Raynor DK, Blenkinsopp A, Knapp P, et al. A systematic review of quantitative and qualitative research on the role and effectiveness of written information available to patients about individual medicines. Health Technol Assess. 2007;11(5):1–160. doi:10.3310/hta11050
  • Hamrosi KK, Aslani P, Raynor DK. Beyond needs and expectations: identifying the barriers and facilitators to written medicine information provision and use in Australia. Heal Expect. 2014;17:220–231. doi:10.1111/j.1369-7625.2011.00753.x
  • Perera T, Ranasinghe P, Perera U, et al. Knowledge of prescribed medication information among patients with limited English proficiency in Sri Lanka. BMC Res Notes. 2012;5(1):658. doi:10.1186/1756-0500-5-658
  • Kyei S. Patients’ information leaflets: its’ influence on ophthalmic patient education and medication compliance. Br J Med Med Res. 2014;4(5):1217–1230. doi:10.9734/BJMMR/2014/6383
  • Jarernsiripornkul N, Phueanpinit P, Pongwecharak J, Krska J. Experiences of and attitudes towards receiving information about non-steroidal anti-inflammatory drugs: a cross-sectional survey of patients in Thailand. Expert Opin Drug Saf. 2016;15:417–426. doi:10.1517/14740338.2016.1139571
  • Koo MM, Krass I, Aslani P, Guzmàn WM, Le Duff M. Factors influencing consumer use of written drug information. Ann Pharmacother. 2003;37(2):259–267. doi:10.1177/106002800303700218
  • Vinker S, Eliyahu V, Yaphe J. The effect of drug information leaflets on patient behavior. Isr Med Assoc J. 2007;9(5):383–386.
  • Nangsangna RD, Da-costa Vroom F. Factors influencing online health information seeking behavior among patients in Kwahu West Municipal, Nkawkaw, Ghana. Online J Public Health Inform. 2019;11(2):e13.
  • Jarernsiripornkul N, Nakboon S, Anarj K, Wongtaweepkij K. Survey of healthcare professionals’ practices, expectations, and attitudes towards provision of patient information leaflets in Thailand. Int J Clin Pharm. 2020;42(2):539–548. doi:10.1007/s11096-020-00965-x
  • Ankrah DNA, Ofei CN. The effect of advice to read the medicine/patient information leaflet among patients in Ghana: a cross-sectional study. J Pharm Heal Serv Res. 2010;1:91–96. doi:10.1111/j.1759-8893.2010.00009.x
  • Phueanpinit P, Pongwecharak J, Krska J, Jarernsiripornkul N. Evaluation of community pharmacists’ roles in screening and communication of risks about non-steroidal anti-inflammatory drugs in Thailand. Prim Heal Care Res Dev. 2018;19:598–604. doi:10.1017/S1463423618000142
  • Phueanpinit P, Pongwecharak J, Sumanont S, Krska J, Jarernsiripornkul N. Physicians’ communication of risks from non-steroidal anti-inflammatory drugs and attitude towards providing adverse drug reaction information to patients. J Eval Clin Pract. 2017;23(6):1387–1394. doi:10.1111/jep.12806